SUBSCRIBE
SUBSCRIBE

Patient recruitment

PRESS RELEASES
Press Releases
Foundation for Sarcoidosis Research (FSR) receives confirmation from the Department of Labor (DOL) ensuring patient access to FMLA for participation in clinical trials
November 18, 2024
 · 
4 min read
Press Releases
UPDATE: PredicineCARE™ Liquid Biopsy Assay Featured in NEJM for patient enrollment in Phase III Breast Cancer Trial
November 7, 2024
 · 
2 min read
Press Releases
Angitia Biopharmaceuticals Announces Dosing of First Patient in Phase 2 Clinical Trial of AGA2118 for the Treatment of Osteoporosis
November 5, 2024
 · 
4 min read
Press Releases
Philips enrolls first patient in U.S. clinical trial for innovative integrated single-device to treat peripheral artery disease
November 5, 2024
 · 
5 min read
Press Releases
Oak Hill Bio and Chiesi Group Announce First European Patient Enrolled in the Phase 2b Clinical Study Evaluating OHB-607 for the Prevention of Bronchopulmonary Dysplasia, the Most Common Cause of Chronic Lung Disease in Premature Infants
November 4, 2024
 · 
7 min read
Press Releases
Memo Therapeutics AG Announces Last Patient Enrolled in Phase II Clinical Trial of Potravitug for Treatment of BK Viremia in Kidney Transplant Patients
November 4, 2024
 · 
2 min read
Press Releases
Sutro Biopharma Announces Initiation of the Registration-enabling REFRαME-P1 Trial with Luvelta for Pediatric Patients with CBF/GLIS AML
November 4, 2024
 · 
7 min read
Press Releases
Record Monthly Enrollment Achieved in SeaStar Medical’s Pivotal Adult AKI Trial
November 4, 2024
 · 
8 min read
Press Releases
Akeso Announces First Patient Enrollment in Phase 3 Trial of Ivonescimab Combination as First-Line Therapy for Biliary Tract Tumors, Compared to Durvalumab
November 1, 2024
 · 
4 min read
Press Releases
First Patient In - BioPorto Initiates Patient Enrollment for US Study of ProNephro AKI (NGAL)™ for Adult Use at Massachusetts General Hospital
October 29, 2024
 · 
5 min read
Press Releases
Aravax Completes Recruitment into Phase 2 Study of PVX108, a novel immunotherapy for the Treatment of Peanut Allergy
October 28, 2024
 · 
3 min read
Press Releases
Pierre Fabre announce 1st Patient Dosed in Phase I/II of PFL-002/VERT-002, a targeted therapy in NSCLC with MET Alterations
October 24, 2024
 · 
2 min read
Press Releases
OKYO Pharma Announces First Patient Dosed in the First Clinical Trial to Treat Neuropathic Corneal Pain
October 24, 2024
 · 
6 min read
Press Releases
Zymeworks Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating ZW171 in Advanced Mesothelin-Expressing Cancers
October 21, 2024
 · 
9 min read
Press Releases
Novo Nordisk A/S: Oral semaglutide demonstrates a 14% reduction in risk of major adverse cardiovascular events in adults with type 2 diabetes in the SOUL trial
October 21, 2024
 · 
3 min read
Press Releases
Oculis Accelerates Enrollment in both DIAMOND Phase 3 Trials of OCS-01 in Diabetic Macular Edema and Expands its DIAMOND Program Committees
October 21, 2024
 · 
7 min read
Press Releases
Endo Presents Data at the American Society of Podiatric Surgeons (ASPS) Annual Surgical Conference
October 20, 2024
 · 
5 min read
Press Releases
Latigo Biotherapeutics Doses First Participant in Phase 1 Clinical Trial of LTG-305 for Non-Opioid Treatment of Pain
October 17, 2024
 · 
3 min read
Press Releases
AVS Enrolls First Patient in U.S. Pivotal Intravascular Lithotripsy Study
October 16, 2024
 · 
2 min read
Press Releases
Ocular Therapeutix™ Announces Accelerated Timelines for SOL-1 Registrational Trial of AXPAXLI™ in Wet AMD
October 15, 2024
 · 
11 min read
Load More